Abbott Laboratories (ABT) recently swept its monthly fair value gap and saw a significant price increase from $102 to $104 on Friday. Despite the jump, there was no specific news driving this above-average ATR daily movement. The stock has been holding above the $100 level, building a solid base, and the chart looks promising. With earnings due on July 18, it's worth monitoring, though no trade will be entered yet. Keep an eye on further developments as the earnings date approaches.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.